Literature DB >> 14643450

Enhanced cell cycle progression and down regulation of p21(Cip1/Waf1) by PRL tyrosine phosphatases.

Sean R Werner1, Paul A Lee, Matthew W DeCamp, Dring N Crowell, Stephen K Randall, Pamela L Crowell.   

Abstract

Human PRL-1, PRL-2, and PRL-3 tyrosine phosphatases induce the malignant transformation of epithelial cells. We tested the hypothesis that the oncogenic effects of PRL occur by increasing cellular proliferation. Cells stably transfected with PRL-1 or PRL-2 exhibited 2.7-3.3-fold increases over control cells in the rate of DNA synthesis and the proportion of cells in S-phase, and they progressed more rapidly from G1 into S. In addition, cells overexpressing either PRL-1 or PRL-2 exhibited enhanced cyclin-dependent kinase 2 (CDK2) activity and significantly lower p21(Cip1/Waf1) protein levels, and PRL-1 overexpressing cells had higher cyclin A protein levels than control cells. We conclude that PRL phosphatases increase cell proliferation by stimulating progression from G1 into S phase, and this process may be dependent on the down regulation of the cyclin dependent kinase inhibitor p21(Cip1/Waf1).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14643450     DOI: 10.1016/s0304-3835(03)00517-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  35 in total

1.  Characterization of farnesylated protein tyrosine phosphatase TcPRL-1 from Trypanosoma cruzi.

Authors:  Ileana C Cuevas; Peter Rohloff; Daniel O Sánchez; Roberto Docampo
Journal:  Eukaryot Cell       Date:  2005-09

2.  PRL-1 protein promotes ERK1/2 and RhoA protein activation through a non-canonical interaction with the Src homology 3 domain of p115 Rho GTPase-activating protein.

Authors:  Yunpeng Bai; Yong Luo; Sijiu Liu; Lujuan Zhang; Kui Shen; Yuanshu Dong; Chad D Walls; Lawrence A Quilliam; Clark D Wells; Youjia Cao; Zhong-Yin Zhang
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

3.  Cellular localization of PRL-1 and PRL-2 gene expression in normal adult human tissues.

Authors:  Carmen M Dumaual; George E Sandusky; Pamela L Crowell; Stephen K Randall
Journal:  J Histochem Cytochem       Date:  2006-09-06       Impact factor: 2.479

4.  PRL2/PTP4A2 phosphatase is important for hematopoietic stem cell self-renewal.

Authors:  Michihiro Kobayashi; Yunpeng Bai; Yuanshu Dong; Hao Yu; Sisi Chen; Rui Gao; Lujuan Zhang; Mervin C Yoder; Reuben Kapur; Zhong-Yin Zhang; Yan Liu
Journal:  Stem Cells       Date:  2014-07       Impact factor: 6.277

Review 5.  Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.

Authors:  Zhi-Hong Yu; Zhong-Yin Zhang
Journal:  Chem Rev       Date:  2017-05-25       Impact factor: 60.622

6.  Phosphatase of regenerating liver-1 promotes cell migration and invasion and regulates filamentous actin dynamics.

Authors:  Masanao Nakashima; John S Lazo
Journal:  J Pharmacol Exp Ther       Date:  2010-05-19       Impact factor: 4.030

7.  Foamy viral vector integration sites in SCID-repopulating cells after MGMTP140K-mediated in vivo selection.

Authors:  M E Olszko; J E Adair; I Linde; D T Rae; P Trobridge; J D Hocum; D J Rawlings; H-P Kiem; G D Trobridge
Journal:  Gene Ther       Date:  2015-03-19       Impact factor: 5.250

8.  Novel Anticancer Agents Based on Targeting the Trimer Interface of the PRL Phosphatase.

Authors:  Yunpeng Bai; Zhi-Hong Yu; Sijiu Liu; Lujuan Zhang; Ruo-Yu Zhang; Li-Fan Zeng; Sheng Zhang; Zhong-Yin Zhang
Journal:  Cancer Res       Date:  2016-06-20       Impact factor: 12.701

Review 9.  Phosphatase of regenerating liver in hematopoietic stem cells and hematological malignancies.

Authors:  Michihiro Kobayashi; Sisi Chen; Rui Gao; Yunpeng Bai; Zhong-Yin Zhang; Yan Liu
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 10.  Phosphatase of regenerating liver: a novel target for cancer therapy.

Authors:  Amanda M Campbell; Zhong-Yin Zhang
Journal:  Expert Opin Ther Targets       Date:  2014-03-01       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.